Rheumatoid arthritis: open trials in Romania

9 open trials have a site in Romania. Registry data; only the trial team decides who can take part.

NCT07363590
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Trial Treatment · Phase 1 · Merck Sharp & Dohme LLC
Arensia Clinics S.R.L., Bucharest · Spitalul Clinic Judetean De Urgenta Cluj, Cluj-Napoca
Registry updated 2026-11-02
NCT07533955
A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
Trial Treatment · Phase 1 · Jade Biosciences, Inc.
Bucharest · Cluj-Napoca
Registry updated 2026-10-23
2025-524746-96-00
Phase 1 Single Dose Study of JADE201 in Participants with Rheumatoid Arthritis
Trial Treatment · Phase 1 · Jade Biosciences Inc.
Arensia Clinics S.R.L., Bucharest · Spitalul Clinic Judetean De Urgenta Cluj, Cluj-Napoca
Registry updated 2026-10-05
2025-525113-22-00
A First-in-Human, Open-label, Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of NBIM-1008 in Patients with Rheumatoid Arthritis
Trial Treatment · Phase 1 · Neurocrine Biosciences Inc.
Arensia Clinics S.R.L., Bucharest · Spitalul Clinic Judetean De Urgenta Cluj, Cluj-Napoca
Registry updated 2026-08-10
NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.
Spitalul Clinic Dr. I. Cantacuzino, Bucharest · Spitalul Clinic Colentina Bucuresti, Bucharest
Registry updated 2026-07-31
NCT07115745
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Institutul Clinic Fundeni, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca
Registry updated 2026-07-14
NCT07433335
A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis
Trial Treatment · Phase 1 · SciRhom GmbH
Arensia Clinics S.R.L., Bucharest · Spitalul Clinic Judetean De Urgenta Cluj, Cluj-Napoca
Registry updated 2026-05-11
2024-520196-27-00
A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid arthritis (RA)
Trial Treatment · Phase 1 · Novartis Pharma AG
Arensia Clinics S.R.L., Bucharest · Spitalul Clinic Judetean De Urgenta Cluj, Cluj-Napoca
Registry updated 2026-04-01
2023-507714-27-00
MethMax trial
Trial Treatment · Phase 4 · Medical University of Vienna
Centrul Clinic De Boli Reumatismale Dr. Ion Stoia, Bucharest
Registry updated 2026-02-02

All Rheumatoid arthritis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error